REFERENCES
- Hall SF, Walker H, Siemens R,
Schneeberg A. Increasing detection and increasing incidence in thyroid
cancer. World journal of surgery: official journal of the
international society of surgery/société internationale de chirurgie .
2009;33(12):2567-2571. doi:10.1007/s00268-009-0226-9
- Sosa J, Hanna J, Robinson K, Lanman, R. (2013). Increases in thyroid
nodule fine-needle aspirations, operations, and diagnoses of thyroid
cancer in the united states. Surgery, 154 (6), 1420-6.
doi:10.1016/j.surg.2013.07.006
- Lewis C, Chang K, Pitman M, Faquin W, Randolph G. (2009). Thyroid
fine-needle aspiration biopsy: Variability in
reporting. Thyroid: Official Journal of the American Thyroid
Association,19 (7), 717-23. doi:10.1089/thy.2008.0425
- Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid
cytopathology. Thyroid. 2017;27(11):1341-1346.
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov
YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG,
Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American
Thyroid Association Management Guidelines for Adult Patients With
Thyroid Nodules and Differentiated Thyroid Cancer: The American
Thyroid Association Guidelines Task Force on Thyroid Nodules and
Differentiated Thyroid Cancer. Thyroid. 2016. Jan;26(1):1-133.
doi: 10.1089/thy.2015.0020
- Varshney R, Forest V-I, Mascarella MA, Zawawi F, Rochon L, Hier MP,
Mlynarek A, Tamilia M, Payne RJ. The mcgill thyroid nodule score –
does it help with indeterminate thyroid nodules? Journal of
otolaryngology - head & neck surgery . 2015;44(1).
doi:10.1186/s40463-015-0058-6
- Valderrabano P, Khazai L, Thompson Z, Leon M, Otto K,
Hallanger-Johnson J, Wadsworth JT, Wenig BM, Chung CH, Centeno BA,
McIver B. (2017). Cancer risk stratification of indeterminate thyroid
nodules: A cytological approach. Thyroid: Official Journal of
the American Thyroid Association,27 (10), 1277-1284.
doi:10.1089/thy.2017.0221
- Mehta V, Nikiforov Y, Ferris RL. (2013). Use of molecular biomarkers
in fna specimens to personalize treatment for thyroid
surgery. Head & Neck, 35 (10), 1499-506.
doi:10.1002/hed.23140
- Bhaijee F, Nikiforov YE. Molecular analysis of thyroid
tumors. Endocrine pathology . 2011;22(3):126-133.
doi:10.1007/s12022-011-9170-y
- Krasner JR, Alyouha N, Pusztaszeri M, Forest VI, Hier MP, Avior G,
Payne RJ. Molecular mutations as a possible factor for determining
extent of thyroid surgery. J Otolaryngol Head Neck Surg .
2019;48(1):1-7. doi:10.1186/s40463-019-0372-5
- Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F,
Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA,
Nikiforov YE. Braf mutations in thyroid tumors are restricted to
papillary carcinomas and anaplastic or poorly differentiated
carcinomas arising from papillary carcinomas. The journal of
clinical endocrinology and metabolism . 2003;88(11):5399-5404.
- Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn
YK, Kim KH, Cho BY, Park DJ. The association of the braf(v600e)
mutation with prognostic factors and poor clinical outcome in
papillary thyroid cancer: a meta-analysis. Cancer .
2012;118(7):1764-1773. doi:10.1002/cncr.26500
- Elisei R, Viola D, Torregrossa L, Giannini R, ROmei C, Ugolini C,
Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G,
Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F. The braf(v600e)
mutation is an independent, poor prognostic factor for the outcome of
patients with low-risk intrathyroid papillary thyroid carcinoma:
single-institution results from a large cohort study. The
journal of clinical endocrinology and metabolism .
2012;97(12):4390-4398. doi:10.1210/jc.2012-1775
- Li C, Lee KC, Schneider EB, Zeiger MA. Braf v600e mutation and its
association with clinicopathological features of papillary thyroid
cancer: a meta-analysis. The journal of clinical endocrinology
and metabolism . 2012;97(12):4559-4570. doi:10.1210/jc.2012-2104
- Xing M, Westra WH, Tufano RP, B Cohen Y, Rosenbaum E, Rhoden KJ,
Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P,
Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD,
Zeiger MA, Sidransky D, Ladenson PW. Braf mutation predicts a poorer
clinical prognosis for papillary thyroid cancer. The journal of
clinical endocrinology and metabolism . 2005;90(12):6373-6379.
- Celik M, Bulbul BY, Ayturk S, Durmus Y, Gurkan H, Can N, Tastekin E,
Ustun F, Sezer A, Guldiken S.The relation between brafv600e mutation
and clinicopathological characteristics of papillary thyroid
cancer. Medicinski glasnik : official publication of the medical
association of zenica-doboj canton, bosnia and herzegovina .
2020;17(1). doi:10.17392/1086-20
- Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ,
Biddinger PW, Nikiforov YE. Correlation between genetic alterations
and microscopic features, clinical manifestations, and prognostic
characteristics of thyroid papillary carcinomas. The american
journal of surgical pathology . 2006;30(2):216-222.
- Patel SG, Carty SE, McCoy KL, Ohori NP, LeBeau SO, Seethala R,
Nikiforova MN, Nikiforov YE, Yip L. Preoperative detection of ras
mutation may guide extent of thyroidectomy. Surgery .
2017;161(1):168-175. doi:10.1016/j.surg.2016.04.054
- Guan H, Toraldo G, Cerda SR, Godley FA, Rao SR, McAneny D, Doherty G,
Braverman L, Lee SL. Utilities of ras mutations in pre-operative fine
needle biopsies for decision-making for thyroid nodule management:
results from a single-center prospective cohort. Thyroid:
official journal of the american thyroid association . 2020;2020 Jan
29. doi:10.1089/thy.2019.0116
- Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P,
Chen H, Doherty GM, Fahey TJ, Kebebew E, Livolsi VA, Perrier ND, Sipos
JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. The american
association of endocrine surgeons guidelines for the definitive
surgical management of thyroid disease in adults. Annals of
surgery . 2020;271(3):93. doi:10.1097/SLA.0000000000003580
- Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip
L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Steward AF,
Nikiforova MN. Impact of mutational testing on the diagnosis and
management of patients with cytologically indeterminate thyroid
nodules: a prospective analysis of 1056 fna samples. The journal
of clinical endocrinology and metabolism . 2011;96(11):3390-3397.
doi:10.1210/jc.2011-1469
- Muzza M, Colombo C, Pogliaghi G, Karapanou O, Fugazzola L. Molecular
markers for the classification of cytologically indeterminate thyroid
nodules. Journal of
endocrinological investigation. 2019;2019 Dec 18.
doi:10.1007/s40618-019-01164-w
- Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, CHudova D, Diggans J,
Friedman L, Kloos RT, Livolsi VA, Mandel SJ, Raab SS, Rosai J, Steward
DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR. Preoperative
diagnosis of benign thyroid nodules with indeterminate
cytology. The new england journal of medicine .
2012;367(8):705-715. doi:10.1056/NEJMoa1203208
- Roth MY, Witt RL, Steward DL. Molecular testing for thyroid nodules:
review and current state. Cancer . 2018;124(5):888-898.
doi:10.1002/cncr.30708
- Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Ngo HTT, Pham TQ,
Tran HM, Gandolfi G, Hassell L. A meta-analysis of prognostic roles of
molecular markers in papillary thyroid carcinoma. Endocrine
connections . 2017;6(3):17. doi:10.1530/EC-17-0010